NCT07048509

Brief Summary

In this study, the investigators will evaluate acute changes in vascular function measures after moderate-intensity continuous and high-intensity interval exercise in healthy and prehypertensive individuals. Participants will be subjected to three separate visits: control condition (30 min rest), moderate-intensity continuous exercise, and high-intensity interval exercise. The investigators will measure aerobic capacity using a cardiopulmonary exercise test (CPET) using indirect gas-exchange to derive subsequent exercise intensity and maximal oxygen uptake. The investigators will evaluate different measures of vascular function (Pulse-wave velocity, Flow-mediated slowing, microvascular function) before and after each condition. The study will involve two groups of participants: healthy individuals and prehypertensive individuals. The investigators aim to establish the reliability and validity of less-established methods of vascular function assessment (flow-mediated slowing and microvascular function) against established measures (pulse-wave velocity). The acute response of vascular function to different exercise intensities has not yet been thoroughly researched using the aforementioned measures in individuals with similar characteristics to the proposed study cohort.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jun 2025Jun 2026

First Submitted

Initial submission to the registry

June 20, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

June 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 22, 2025

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

June 20, 2025

Last Update Submit

December 15, 2025

Conditions

Keywords

aerobic exercisevascular functionprehypertension

Outcome Measures

Primary Outcomes (3)

  • Arterial stiffness

    Arterial stiffness will be measured by pulse wave velocity

    At the beginning of each visit (T0) and immediately after each acute stimulus (T1)

  • Microvascular function

    Microvascular function will be mesured using near-infrared spectroscopy during and after a 5-minute occlusion of the brachial artery.

    At the beginning of each visit (T0) and immediately after each acute stimulus (T1)

  • Flow-mediated slowing

    Flow-mediated slowing will be measured by pulse wave velocity deceleration after occlusion of the brachial artery.

    At the beginning of each visit (T0) and immediately after each acute stimulus (T1)

Secondary Outcomes (3)

  • Aerobic capacity

    Baseline

  • Blood pressure

    Baseline

  • Blood markers

    At the beginning of each visit (T0) and immediately after each acute stimulus (T1)

Study Arms (2)

Normotensive

PLACEBO COMPARATOR

Normotensives with ambulatory blood pressure measurements within the optimal range according to the 2023 ESH guidelines

Other: Control-no treatmentOther: Exercise

Prehypertensive

ACTIVE COMPARATOR

Prehypertensives with blood pressure within 120-139 mmHg systolic and/or 80-89 diastolic.

Other: Control-no treatmentOther: Exercise

Interventions

30 minutes of rest

NormotensivePrehypertensive

30 minutes of Moderate-Intensity Continuous Exercise

NormotensivePrehypertensive

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age, BMI \< 30, blood pressure (BP) within the optimal range according to the latest ESH guidelines (\< 120 mmHg systolic and/or \< 80 mmHg diastolic BP)
  • Sedentary or low active according to the Global Physical Activity Questionnaire (GPAQ) (Armstrong \& Bull, 2006; Lim et al., 2012)
  • No prescribed medication and absence of chronic diseases
  • years of age, BMI \< 30
  • Diagnosed prehypertension by a clinican from the Hypertension clinic, University clinical centre of Ljubljana using established criteria
  • Sedentary or low or moderately active according to the Global Physical Activity Questionnaire (GPAQ)
  • No prescribed medication and absence of chronic diseases

You may not qualify if:

  • Blood pressure out of the optimal range (normotensives)
  • High level of phyisical activity (moderate or high active according to GPAQ)
  • Hypotension
  • Chronic diseases
  • Prescribed medication
  • Lower extremity injury in the last six months
  • Menopause
  • Absence of normal menstrual cycle
  • Pregnancy
  • Smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ljubljana, Faculty of sport

Ljubljana, 1000, Slovenia

RECRUITING

MeSH Terms

Conditions

PrehypertensionHypertension

Interventions

Exercise

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Armin H Paravlic, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
CROSSOVER
Model Details: Prospective double-blind crossover randomized study design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2025

First Posted

July 2, 2025

Study Start

June 24, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

December 22, 2025

Record last verified: 2025-12

Locations